D75.81: Myelofibrosis
D75.81 is a billable, specific ICD-10-CM code for myelofibrosis. It is valid for submission on a claim.
Check D75.81 with the rest of the claim: free scrubberExcludes1: never code together
These conditions cannot occur together. Billing both on the same encounter is a denial.
Code first
The underlying condition must be sequenced before this code.
- the underlying disorder, such as:
- malignant neoplasm of breast (C50.-)
Use additional code
Add a secondary code to capture the detail described below.
Inclusion terms
Alternative wordings a physician may use in the chart for this same code.
- Myelofibrosis NOS
- Secondary myelofibrosis NOS
Excludes2 inherited from the categories above D75.81
Not part of this code, but both may be coded when both are present.
Other codes that can never be billed with D75.81
Their own Excludes1 notes name this code, so the conflict is not listed above.
Risk adjustment
D75.81 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:
- HCC 19 Myelodysplastic Syndromes, Multiple Myeloma, and Other Cancers1.798 RAF
Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.
Medicare coverage
D75.81 is named in 38 Medicare coverage policies: 38 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.
- A52986Billing and Coding: Biomarkers for Oncology
- A55717Billing and Coding: Lab: Flow Cytometry
- A56199Billing and Coding: Molecular Pathology Procedures
- A56421Billing and Coding: CT of the Abdomen and Pelvis
Alphabetic index entries that lead here
- Myelofibrosis
- Anemia›myelofibrosis
- Myelofibrosis›secondary
- Osteosclerosis›myelofibrosis
Code history
Unchanged in every release from FY2024 to FY2027.